Please assess the completion status of the following clinical trial:

Trial Title: High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Older than 18 years old~* Scheduled for 5 or 6 Fr diagnostic coronary angiography~* The interventional cardiologist is willing to proceed with radial access~* Written informed consent~Exclusion Criteria:~Before randomization~* chronic hemodialysis~* oral anticoagulation~* hemodynamic instability~* severe dermo-myoskeletal forearm deformities~* history of CABG and bilateral use of either the internal mammary or radial artery~* history of CABG and ipsilateral use of both the internal mammary and radial artery~* admission for elective PCI After randomization~* crossover to another arterial access site is required~* ad hoc PCI

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard dose of Heparin (Type: ACTIVE_COMPARATOR): 50IU/Kg heparin intravenously
- High dose of Heparin (Type: EXPERIMENTAL): 100IU/Kg heparin intravenously

Based on this trial design, predict the completion outcome and termination type (if applicable).